FALCON POINT CAPITAL, LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
FALCON POINT CAPITAL, LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2016$277,000
-21.5%
64,369
-15.6%
0.05%
-21.3%
Q1 2016$353,000
+44.1%
76,259
+1042.3%
0.06%
-67.9%
Q1 2015$245,0006,6760.19%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2016
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders